Bioorganic and Medicinal Chemistry Letters p. 3081 - 3086 (1998)
Update date:2022-07-31
Topics:
Kuo, Michelle S.
Bock, Mark G.
Freidinger, Roger M.
Guidotti, Maribeth T.
Lis, Edward V.
Pawluczyk, Joseph M.
Perlow, Debra S.
Pettibone, Douglas J.
Quigley, Amy G.
Reiss, Duane R.
Williams, Peter D.
Woyden, Carla J.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257) have identified a new series of high affinity, receptor-selective OT antagonists in which the N-acetyl-4-piperidinyl ether terminus in 1 has been replaced with a 1-(aryl)ethoxy group.
View MoreShenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Doi:10.1016/S0040-4020(97)00697-2
(1997)Doi:10.1021/jo001710q
(2001)Doi:10.1021/ja01871a037
(1939)Doi:10.1021/ja971574f
(1997)Doi:10.1021/jm970085n
(1997)Doi:10.1021/acs.joc.8b01737
(2018)
